Macular Atrophy Progression and 7-Year Vision Outcomes in Subjects From the ANCHOR, MARINA, and HORIZON Studies: The SEVEN-UP Study

被引:5
作者
Brijesh, Takkar
Shorya, Azad
机构
关键词
DEGENERATION; RANIBIZUMAB; TRIAL;
D O I
10.1016/j.ajo.2015.11.002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:200 / 200
页数:1
相关论文
共 5 条
[1]   Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions [J].
Aronow, Mary E. ;
Chew, Emily Y. .
CURRENT OPINION IN OPHTHALMOLOGY, 2014, 25 (03) :186-190
[2]   Macular Atrophy Progression and 7-Year Vision Outcomes in Subjects From the ANCHOR, MARINA, and HORIZON Studies: the SEVEN-UP Study [J].
Bhisitkul, Robert B. ;
Mendes, Thais S. ;
Rofagha, Soraya ;
Enanoria, Wayne ;
Boyer, David S. ;
Sadda, Srinivas R. ;
Zhang, Kang .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 159 (05) :915-924
[3]   Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study [J].
Brown, David M. ;
Michels, Mark ;
Kaiser, Peter K. ;
Heier, Jeffrey S. ;
Sy, Judy P. ;
Ianchulev, Tsontcho .
OPHTHALMOLOGY, 2009, 116 (01) :57-65
[4]   Improved vision-related function after ranibizumab treatment of Neovascular age-related macular degeneration - Results of a randomized clinical trial [J].
Chang, Tom S. ;
Bressler, Neil M. ;
Fine, Jennifer T. ;
Dolan, Chantal W. ;
Ward, James ;
Klesert, Todd R. .
ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (11) :1460-1469
[5]   HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration [J].
Singer, Michael A. ;
Awh, Carl C. ;
Sadda, SriniVas ;
Freeman, William R. ;
Antoszyk, Andrew N. ;
Wong, Pamela ;
Tuomi, Lisa .
OPHTHALMOLOGY, 2012, 119 (06) :1175-1183